Trump Says US Approves Second Covid-19 Vaccine



[ad_1]

Moderna’s Covid-19 vaccine was approved and distributed immediately, Trump said, although the pharmaceutical regulator has yet to announce a decision.

“Moderna Vaccine is overwhelmingly approved. Distribution will begin immediately,” US President Donald Trump wrote on Twitter on December 18.

Previously, advisers from the United States Food and Drug Administration (FDA) met on December 17 and concluded that Moderna’s Covid-19 vaccine offers benefits outweighs the risks and supports its use. with 20 votes in favor and no votes. The FDA plans to announce its decision a day later.

However, at a vaccination event in Washington, US Vice President Mike Pence and an FDA representative said the Moderna vaccine had not been approved. “Americans can be sure that we have one and two vaccines that are safe in a few hours,” Pence said.

US President Donald Trump during a ceremony at the White House on December 3.  Photo: Reuters.

US President Donald Trump during a ceremony at the White House on December 3. Image: Reuters.

On December 11, the FDA urgently approved the first Covid-19 vaccine developed by Pfizer and BioNTech, prioritizing injections for frontline healthcare workers and the elderly in nursing homes. In July, the US government struck a deal to purchase 100 million doses of Pfizer and BioNTech vaccines, worth $ 1.95 billion, to inject about 50 million people.

Moderna began developing the Covid-19 vaccine in January, completing the Covid-19 vaccine trial after Pfizer and BioNTech. Moderna’s Covid-19 vaccine was developed using informational RNA synthesis technology, with two injections spaced approximately 28 days apart, and does not require storage at extremely low temperatures like Pfizer and BioNTech products.

The Covid-19 outbreak in December 2019 appeared in 218 countries and territories with more than 75.4 million cases, almost 1.7 million deaths, and almost 53 million people recovered. The United States is the largest epidemic area in the world with more than 17.6 million cases and nearly 318,000 deaths. Covid-19 has forced many countries to invest unprecedented resources to rapidly develop vaccines.

Nguyen tien (According to the Reuters)

[ad_2]